First-in-Human Trial Reports Promising Dual Lassa–Rabies Vaccine Data
Researchers reported promising interim results from a Phase I clinical trial testing a new dual vaccine against Lassa fever and rabies.
The post First-in-Human Trial Reports Promising Dual Lassa–Rabies Vaccine Data appeared first on GEN - Genetic Engineering and Biotechnology News.
